Product Information
LOXAPINE 50 MG CAPSULE is a generic product labeled by Lannett Company Inc., priced at $0.9748 per EA under NDC 00527139701. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
50 mg/1
Manufacturer
Lannett Company Inc.NDC
00527139701
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LOXAPINE SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA090695On Market Since
9/26/2011
Price Statistics
The NADAC for LOXAPINE 50 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 2.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9748 per EA |
|---|---|
| All-time high | $1.4265 (Jun 14, 2023) |
| All-time low | $0.7084 (Sep 19, 2018) |
| 52-week high | $0.9748 |
| 52-week low | $0.8779 |
| Median price | $0.8779 |
| Average price | $0.8923 |
| Largest weekly change | +41.3% (Feb 21, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LOXAPINE 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LOXAPINE 50 MG CAPSULE, manufactured by Lannett Company Inc., is $0.9748 per EA (NDC 00527139701), effective Jun 24, 2026.
How has the price of LOXAPINE 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LOXAPINE 50 MG CAPSULE has risen 2.7%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LOXAPINE 50 MG CAPSULE?
Since Nov 28, 2013, the NADAC for LOXAPINE 50 MG CAPSULE has ranged from a low of $0.7084 (Sep 19, 2018) to a high of $1.4265 (Jun 14, 2023), with a median of $0.8779 per EA.
Are there cheaper alternatives to LOXAPINE 50 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as LOXAPINE 50 MG CAPSULE, but none are currently priced below it.
Who manufactures LOXAPINE 50 MG CAPSULE?
LOXAPINE 50 MG CAPSULE (NDC 00527139701) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification